Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent Pneumococcal Polysaccharide Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of 23-Valent Pneumococcal Polysaccharide Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the 23-Valent Pneumococcal Polysaccharide Vaccine market.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
Key Features:
The report on 23-Valent Pneumococcal Polysaccharide Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the 23-Valent Pneumococcal Polysaccharide Vaccine market. It may include historical data, market segmentation by Type (e.g., Single Dose Vial, Pre-filled Syringe), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the 23-Valent Pneumococcal Polysaccharide Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the 23-Valent Pneumococcal Polysaccharide Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the 23-Valent Pneumococcal Polysaccharide Vaccine industry. This include advancements in 23-Valent Pneumococcal Polysaccharide Vaccine technology, 23-Valent Pneumococcal Polysaccharide Vaccine new entrants, 23-Valent Pneumococcal Polysaccharide Vaccine new investment, and other innovations that are shaping the future of 23-Valent Pneumococcal Polysaccharide Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the 23-Valent Pneumococcal Polysaccharide Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for 23-Valent Pneumococcal Polysaccharide Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the 23-Valent Pneumococcal Polysaccharide Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting 23-Valent Pneumococcal Polysaccharide Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the 23-Valent Pneumococcal Polysaccharide Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Market Segmentation:
23-Valent Pneumococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global 23-Valent Pneumococcal Polysaccharide Vaccine market?
What factors are driving 23-Valent Pneumococcal Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 23-Valent Pneumococcal Polysaccharide Vaccine market opportunities vary by end market size?
How does 23-Valent Pneumococcal Polysaccharide Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent Pneumococcal Polysaccharide Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of 23-Valent Pneumococcal Polysaccharide Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the 23-Valent Pneumococcal Polysaccharide Vaccine market.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
Key Features:
The report on 23-Valent Pneumococcal Polysaccharide Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the 23-Valent Pneumococcal Polysaccharide Vaccine market. It may include historical data, market segmentation by Type (e.g., Single Dose Vial, Pre-filled Syringe), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the 23-Valent Pneumococcal Polysaccharide Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the 23-Valent Pneumococcal Polysaccharide Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the 23-Valent Pneumococcal Polysaccharide Vaccine industry. This include advancements in 23-Valent Pneumococcal Polysaccharide Vaccine technology, 23-Valent Pneumococcal Polysaccharide Vaccine new entrants, 23-Valent Pneumococcal Polysaccharide Vaccine new investment, and other innovations that are shaping the future of 23-Valent Pneumococcal Polysaccharide Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the 23-Valent Pneumococcal Polysaccharide Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for 23-Valent Pneumococcal Polysaccharide Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the 23-Valent Pneumococcal Polysaccharide Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting 23-Valent Pneumococcal Polysaccharide Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the 23-Valent Pneumococcal Polysaccharide Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Market Segmentation:
23-Valent Pneumococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Single Dose Vial
- Pre-filled Syringe
- For Children (Over 2 Years Old)
- For Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Sinovac
- Kangtai Bio
- CDIBP
- Walvax
What is the 10-year outlook for the global 23-Valent Pneumococcal Polysaccharide Vaccine market?
What factors are driving 23-Valent Pneumococcal Polysaccharide Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 23-Valent Pneumococcal Polysaccharide Vaccine market opportunities vary by end market size?
How does 23-Valent Pneumococcal Polysaccharide Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2019, 2023 & 2030
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (Over 2 Years Old)
2.4.2 For Adult
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024)
3 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY COMPANY
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2025-2030)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sinovac
13.2.1 Sinovac Company Information
13.2.2 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sinovac Main Business Overview
13.2.5 Sinovac Latest Developments
13.3 Kangtai Bio
13.3.1 Kangtai Bio Company Information
13.3.2 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Kangtai Bio Main Business Overview
13.3.5 Kangtai Bio Latest Developments
13.4 CDIBP
13.4.1 CDIBP Company Information
13.4.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CDIBP Main Business Overview
13.4.5 CDIBP Latest Developments
13.5 Walvax
13.5.1 Walvax Company Information
13.5.2 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Walvax Main Business Overview
13.5.5 Walvax Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2019, 2023 & 2030
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (Over 2 Years Old)
2.4.2 For Adult
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024)
3 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY COMPANY
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 AMERICAS
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 WORLD FORECAST REVIEW FOR 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY GEOGRAPHIC REGION
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2025-2030)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sinovac
13.2.1 Sinovac Company Information
13.2.2 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sinovac Main Business Overview
13.2.5 Sinovac Latest Developments
13.3 Kangtai Bio
13.3.1 Kangtai Bio Company Information
13.3.2 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Kangtai Bio Main Business Overview
13.3.5 Kangtai Bio Latest Developments
13.4 CDIBP
13.4.1 CDIBP Company Information
13.4.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CDIBP Main Business Overview
13.4.5 CDIBP Latest Developments
13.5 Walvax
13.5.1 Walvax Company Information
13.5.2 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
13.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Walvax Main Business Overview
13.5.5 Walvax Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2024)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 58. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 59. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 60. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 63. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Sinovac Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Sinovac Main Business
Table 87. Sinovac Latest Developments
Table 88. Kangtai Bio Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Kangtai Bio Main Business
Table 92. Kangtai Bio Latest Developments
Table 93. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 95. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. CDIBP Main Business
Table 97. CDIBP Latest Developments
Table 98. Walvax Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 100. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Walvax Main Business
Table 102. Walvax Latest Developments
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2024) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2024)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2024)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2024) & (K Units)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2024)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2024)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2019-2024)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2019-2024)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019-2024) & (K Units)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2019-2024)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2019-2024)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 58. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 59. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 60. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 63. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 80. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Sinovac Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 85. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Sinovac Main Business
Table 87. Sinovac Latest Developments
Table 88. Kangtai Bio Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 90. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Kangtai Bio Main Business
Table 92. Kangtai Bio Latest Developments
Table 93. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 95. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. CDIBP Main Business
Table 97. CDIBP Latest Developments
Table 98. Walvax Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolios and Specifications
Table 100. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Walvax Main Business
Table 102. Walvax Latest Developments
LIST OF FIGURES
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2023
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (Over 2 Years Old)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (Over 2 Years Old) (2019-2024) & (K Units)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Adult
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Adult (2019-2024) & (K Units)
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2023)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 19. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2023
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2023
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2023
Figure 71. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 72. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 73. Channels of Distribution
Figure 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2023
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2019-2024)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (Over 2 Years Old)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (Over 2 Years Old) (2019-2024) & (K Units)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Adult
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Adult (2019-2024) & (K Units)
Figure 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2023)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 19. 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market by Company in 2023 (K Units)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2023
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2023
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2023
Figure 25. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 26. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 27. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 28. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2023
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2023
Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 45. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 56. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 57. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2023
Figure 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2019-2024)
Figure 65. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2023
Figure 71. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 72. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 73. Channels of Distribution
Figure 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region (2025-2030)
Figure 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2025-2030)
